Cytokine-induced Neurohumoral Excitation in Heart Failure
心力衰竭中细胞因子诱导的神经体液兴奋
基本信息
- 批准号:7664881
- 负责人:
- 金额:$ 33.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-15 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAngiotensin II ReceptorAngiotensin-Converting Enzyme InhibitorsAngiotensinsAnimalsAttenuatedBiochemicalBiologicalBrainCardiacCardiovascular systemChemicalsChronicClinicalCongestive Heart FailureCytokine ActivationDataDiseaseDisease ProgressionDoctor of PhilosophyElectric StimulationEquilibriumFluid BalanceFunctional disorderHeartHeart BlockHeart failureHormonesHypothalamic structureImmuneImmunohistochemistryIn Situ HybridizationIndividualInfarctionInfusion proceduresInterleukin-1 alphaInterleukin-1 betaInterleukin-6KidneyKnockout MiceLasersLeadLeft Ventricular DysfunctionLightLinkLiquid substanceMeasuresMediatingMediator of activation proteinMessenger RNAMicroscopyMineralocorticoid ReceptorMolecularMorbidity - disease rateMusMyocardial InfarctionMyocardiumNamesNerveNeuraxisNeurohormonesPathogenesisPathway interactionsPatientsPeptidesPerfusionPeripheralPlasmaPlayProcessProteinsPulmonary EdemaRattusRegulationReninRenin-Angiotensin SystemReportingResearchReverse Transcriptase Polymerase Chain ReactionRoleSodiumSpironolactoneSystemTherapeuticThird ventricle structureTimeTime StudyTissuesTumor Necrosis Factor-alphaVentricular RemodelingWaterbasecytokineend stage diseasein vivoinhibitor/antagonistmortalitymouse modeloutcome forecastparaventricular nucleusprematurereceptor
项目摘要
DESCRIPTION (provided by applicant): Chronic congestive heart failure is characterized by neurohumoral excitation (NHE) that contributes to the progression of end-stage disease and the premature demise of the patient. In the past few decades, most of the therapeutic measures were targeted against the activation of the neurohormonal system, and these strategies have clearly reduced mortality and morbidity. However, the clinical course of heart failure (HF) is progressive and the long-term prognosis remains dismal, suggesting that other mediators might be involved in NHE. Currently, immune mediated mechanisms have been recognized to play an important role in the pathogenesis of HF. Recently, we reported for the first time that cytokines are activated in the brain early after myocardial infarction. We also showed that blockade of cytokines attenuated NHE and angiotensin II receptor protein in the hypothalamus and the heart of HF rats. Therefore, we hypothesize that cytokines, acting either directly or via an interaction with the renin-angiotensin system (RAS), contribute to NHE in heart failure. The specific aims of this application are: 1. Peripheral cytokines drive NHE in heart failure, either directly or via an interaction with the peripheral RAS. 2. Central nervous system cytokines activate NHE in heart failure, either directly or via an interaction with products of intrinsic brain RAS. 3. Cardiac sympathetic afferents contribute to brain cytokine activation and bring about NHE in heart failure. This proposal will focus on understanding the contribution of peripheral and central nervous system influences of three cytokines (interleukin-1beta, tumor necrosis factor-alpha and interleukin-6) and angiotensin on NHE in HF. This will be accomplished by integrating a combination of molecular, cellular, electrophysiological and in vivo (rat and mouse model of HF) experimental approaches. The central link between cytokines and the neurohumoral system in HF may lead to a better understanding of the progression of the disease process and ultimately lead to new and effective strategies to treat HF.
描述(由申请人提供):慢性充血性心力衰竭的特征是神经体液兴奋(NHE),其有助于终末期疾病的进展和患者的过早死亡。在过去的几十年里,大多数治疗措施都针对神经激素系统的激活,这些策略明显降低了死亡率和发病率。然而,心力衰竭(HF)的临床过程是渐进的,长期预后仍然令人沮丧,这表明其他介质可能参与NHE。目前,免疫介导的机制已被认为在HF的发病机制中发挥重要作用。最近,我们首次报道了心肌梗死后早期脑内细胞因子的激活。我们还发现,阻断细胞因子减弱了HF大鼠下丘脑和心脏中的NHE和血管紧张素II受体蛋白。因此,我们假设细胞因子,直接或通过与肾素-血管紧张素系统(RAS)的相互作用,有助于心力衰竭的NHE。本申请的具体目的是:1.外周细胞因子直接或通过与外周RAS的相互作用驱动心力衰竭中的NHE。2.中枢神经系统细胞因子直接或通过与内源性脑RAS产物的相互作用激活心力衰竭中的NHE。3.心脏交感神经传入参与脑细胞因子激活,导致心力衰竭时的NHE。本提案将集中于了解外周和中枢神经系统的影响,三种细胞因子(白细胞介素-1 β,肿瘤坏死因子-α和白细胞介素-6)和血管紧张素对NHE在HF的贡献。这将通过整合分子、细胞、电生理和体内(大鼠和小鼠HF模型)实验方法的组合来实现。HF中细胞因子和神经体液系统之间的中心联系可能导致更好地理解疾病过程的进展,并最终导致治疗HF的新的有效策略。
项目成果
期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction.
- DOI:10.1016/j.freeradbiomed.2008.10.049
- 发表时间:2009-02-15
- 期刊:
- 影响因子:7.4
- 作者:Mariappan, Nithya;Elks, Carrie M.;Fink, Bruno;Francis, Joseph
- 通讯作者:Francis, Joseph
Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
- DOI:10.1371/journal.pone.0138372
- 发表时间:2015
- 期刊:
- 影响因子:3.7
- 作者:Sriramula S;Francis J
- 通讯作者:Francis J
Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL.
- DOI:10.1038/oby.2009.137
- 发表时间:2009-11
- 期刊:
- 影响因子:6.9
- 作者:Ebenezer, Philip J.;Mariappan, Nithya;Elks, Carrie M.;Haque, Masudul;Francis, Joseph
- 通讯作者:Francis, Joseph
Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats.
- DOI:10.1016/j.lfs.2009.06.019
- 发表时间:2009-08-26
- 期刊:
- 影响因子:6.1
- 作者:Ebenezer, Philip J.;Mariappan, Nithya;Elks, Carrie M.;Haque, Masudul;Soltani, Zohreh;Reisin, Efrain;Francis, Joseph
- 通讯作者:Francis, Joseph
Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension.
TNF在大脑中的抑制会逆转RAS成分的改变,并减弱血管紧张素II诱导的高血压。
- DOI:10.1371/journal.pone.0063847
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Sriramula S;Cardinale JP;Francis J
- 通讯作者:Francis J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH FRANCIS其他文献
JOSEPH FRANCIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH FRANCIS', 18)}}的其他基金
Cytokine-induced Neurohumoral Excitation in Heart Failure
心力衰竭中细胞因子诱导的神经体液兴奋
- 批准号:
7269498 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
Cytokine-induced NeurohumoralExcitation in Heart Failure
心力衰竭中细胞因子诱导的神经体液兴奋
- 批准号:
6905136 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
Cytokine-induced NeurohumoralExcitation in Heart Failure
心力衰竭中细胞因子诱导的神经体液兴奋
- 批准号:
7107952 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
Cytokine-induced Neurohumoral Excitation in Heart Failure
心力衰竭中细胞因子诱导的神经体液兴奋
- 批准号:
7484205 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
Biomedical Research Experience for Veterinary Students
兽医学生的生物医学研究经验
- 批准号:
10393528 - 财政年份:2003
- 资助金额:
$ 33.75万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Operating Grants
Antitumor effect of HCC and exosome microRNA by angiotensin II receptor blockers and molecular target drugs
血管紧张素II受体阻滞剂和分子靶向药物对HCC和外泌体microRNA的抗肿瘤作用
- 批准号:
19K17401 - 财政年份:2019
- 资助金额:
$ 33.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects
血管紧张素 II 受体阻滞剂对内皮功能的多效性激活对其保护性抗血管重塑作用至关重要
- 批准号:
411570 - 财政年份:2019
- 资助金额:
$ 33.75万 - 项目类别:
Heterogeneity of Angiotensin II Receptor Blockers in the inhibition of Marfan-associated Aortic Root Dilation Independent of Blood Pressure Effects
血管紧张素 II 受体阻滞剂抑制马凡相关主动脉根部扩张的异质性,与血压影响无关
- 批准号:
391615 - 财政年份:2018
- 资助金额:
$ 33.75万 - 项目类别:
Relationship between serum EETs concentrations and cardiovascular events in patients taking angiotensin II receptor blockers
服用血管紧张素II受体阻滞剂的患者血清EETs浓度与心血管事件的关系
- 批准号:
26460229 - 财政年份:2014
- 资助金额:
$ 33.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The development of new angiotensin II receptor vaccine
新型血管紧张素II受体疫苗的研制
- 批准号:
25870715 - 财政年份:2013
- 资助金额:
$ 33.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Central GRK5 modulation of Angiotensin II receptor expression in heart failure
GRK5 对心力衰竭中血管紧张素 II 受体表达的中枢调节
- 批准号:
8531707 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
Central GRK5 modulation of Angiotensin II receptor expression in heart failure
GRK5 对心力衰竭中血管紧张素 II 受体表达的中枢调节
- 批准号:
8397394 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别: